nanoparticle based peptides (EnduRx Pharmaceuticals)

N/A

Report date: 2025/03/20 14:56:48

Base Information

Drug Namenanoparticle based peptides (EnduRx Pharmaceuticals)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEndurx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEndurx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A